Literature DB >> 28787558

Hidradenitis suppurativa - Management, comorbidities and monitoring.

Dunja A Vekic, Geoffrey D Cains.   

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease presenting in intertriginous areas. HS is associated with a number of disease-modifying comorbidities, including metabolic syndrome and androgen dysfunction, and smoking.
OBJECTIVE: This review provides a synopsis of the aetiology and diagnosis of HS, and an overview of management for this often devastating disease. DISCUSSION: The clinical course and disease severity of HS are variable among patients. HS has profound physical and psychological consequences that affect patients' quality of life. Effective treatment is now a realistic goal, but needs to be combined with treatment of the comorbidities and psyche. Evidence-based management guidelines have been established for the management of this disease. General practitioners play a pivotal role in the holistic treatment of this disease.

Entities:  

Mesh:

Year:  2017        PMID: 28787558

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  6 in total

Review 1.  Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils.

Authors:  Vishnu Hosur; Daniel A Skelly; Christopher Francis; Benjamin E Low; Vivek Kohar; Lisa M Burzenski; Mansoor M Amiji; Leonard D Shultz; Michael V Wiles
Journal:  Drug Discov Today       Date:  2020-05-05       Impact factor: 7.851

2.  Impact of a hidradenitis suppurativa patient decision aid on treatment decision making: A randomized controlled trial.

Authors:  Donna McLean; Olivia McBride; Tanja Samardzic; Mia Sisic; Robert P Dellavalle; Jerry Tan
Journal:  JAAD Int       Date:  2020-10-29

Review 3.  Non-contrast-enhanced 3-Tesla Magnetic Resonance Imaging Using Surface-coil and Sonography for Assessment of Hidradenitis Suppurativa Lesions.

Authors:  Fatemeh Jabbary Lak; Mona Mazinani; Johannes T Heverhagen; Robert E Hunger; Keivan Daneshvar; S Morteza Seyed Jafari
Journal:  Acta Derm Venereol       Date:  2020-11-12       Impact factor: 3.875

4.  Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa.

Authors:  Astrid-Helene Ravn Jørgensen; Yiqiu Yao; Simon Francis Thomsen
Journal:  Case Rep Dermatol Med       Date:  2018-04-16

Review 5.  Efficacy and Toxicity of Classical Immunosuppressants, Retinoids and Biologics in Hidradenitis Suppurativa.

Authors:  Kinnor Das; Steven Daveluy; George Kroumpouzos; Komal Agarwal; Indrashis Podder; Katherine Farnbach; Alex G Ortega-Loayza; Jacek C Szepietowski; Stephan Grabbe; Mohamad Goldust
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

Review 6.  Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.

Authors:  S Morteza Seyed Jafari; Robert E Hunger; Christoph Schlapbach
Journal:  Front Med (Lausanne)       Date:  2020-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.